Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

PepGen IPO nabs $108M for muscular dystrophy drug with potential edge over Sarepta med,

Biotech company PepGen is developing a drug that delivers its … Preliminary data from the clinical trial are expected by the end of this year., Biotech company PepGen is developing a drug that delivers its … Preliminary data from the clinical trial are expected by the end of this year., Read More

Scroll to Top